Monday, July 25, 2022

Novavax COVID-19 Vaccine

Received this email from a friend? Sign up now

CDC Centers for Disease Control and Prevention CDC 24/7: Saving Lives, Protecting People
Coronavirus Disease 2019 (COVID-19)
July 25, 2022
This message includes updates on the COVID-19 response from CDC. The COVID-19 Outbreak is a rapidly evolving situation and information will be updated as it becomes available.
Picture of woman with bandage.

Novavax COVID-19 Vaccine


CDC has endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation that Novavax’s COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

Novavax is a protein subunit vaccine. These vaccines package harmless proteins of the COVID-19 virus alongside another ingredient called an adjuvant that helps the immune system respond to the virus in the future.

Vaccines using protein subunits have been used for more than 30 years in the United States, beginning with the first licensed hepatitis B vaccine. Other protein subunit vaccines used in the United States today include those to protect against influenza and whooping cough.

Two doses of Novavax are given in the primary series, 3–8 weeks apart. People who are moderately or severely immunocompromised should also receive 2 doses, given 3 weeks apart (a 3rd primary dose is not currently authorized).

Novavax COVID-19 vaccine is not authorized for use as a booster dose.

Illustration of a checklist on a tablet.

V-safe After Vaccination Health Checker


Use your smartphone to tell CDC how you, or your dependent, feel after getting any dose of the COVID-19 vaccine. Your participation in V-safe helps CDC monitor the safety of COVID-19 vaccines for everyone.

V-safe provides personalized and confidential health check-ins via text messages and web surveys so you can quickly and easily share with CDC how you, or your dependent, feel after getting a COVID-19 vaccine.

V-safe features:
  • Enrolling is fast and easy! Sign up during the waiting period after you get any dose of COVID-19 vaccine or at any time after vaccination
  • Add a dependent and complete health check-ins on their behalf
  • Enter and report how you, or your dependent, feel after first, second, additional, and booster doses
  • Available in multiple languages including English, Spanish, Chinese, Korean, and Vietnamese
CDC's COVID Data Tracker Weekly Review, Friday July 22, 2022 - Learn About Booster Rates in Your County - Find the latest data in CDC's COVID Data Tracker Weekly Review - Subscribe: bit.ly/CDTsubscribe

COVID Data Tracker Weekly Review


Staying up to date on COVID-19 vaccines, including boosters, offers the best protection against severe COVID-19. However, millions of people in the U.S. eligible for boosters have not gotten theirs.

COVID-19 Community Levels


CDC uses COVID-19 Community Levels to determine the disease’s impact on counties and recommend prevention measures.


CDC also tracks cases, laboratory tests, vaccinations, deaths, and other pandemic data and provides them on our COVID Data Tracker.



U.S. map showing COVID-19 Community Levels

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe

FDA authorizes Pemgarda to help prevent COVID-19 for immunocompromised people

This message includes updates on respiratory viruses from CDC. Received this email from a friend? Sign up now View this email in your web br...